Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide

Arzneimittel-Forschung/Drug Research

Volumn 54, Issue 12, 2004, Pages 857-867

  Doi, Naomi ^a   Hirotani, Chiharu ^a   Ukai, Kiyoharu ^a   Shimada, Osafumi ^a   Okuno, Tadashi ^a   Kurasaki, Shigeru ^a   Kiyofuji, Takeshi ^a   Ikegami, Reiko ^a   Futamata, Machiko ^a   Nakagawa, Terutake ^a   Ase, Katsuhiko ^a   Chihara, Kazuo ^b  

^a KAKEN PHARMACEUTICAL CO LTD   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CAS 158861 67 7; Growth hormone releasing peptide 2; Hypothalamus; KP 102, growth hormone releasing property, Pharmacology; Pituitary; Pralmorelin

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; GLUTAMATE SODIUM; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; PRALMORELIN; PROLACTIN;

ADENOHYPOPHYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE RELEASE; CORTICOTROPIN RELEASE; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HYPOPHYSECTOMY; MALE; MEDIAN EMINENCE; NEUROENDOCRINOLOGY; NONHUMAN; PROLACTIN RELEASE; RAT;

EID: 10644241631     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1297041     Document Type: Article

References (44)

1. Devesa, J., Lima, L., Tresguerres, J. A. F., Neuroendocrine control of growth hormone secretion in human. Trends Endocrinol. Metab. 3, 173 (1992)
2. Schalch, D. S., Reichlin, S., Plasma growth hormone concentration in the rat determined by radioimmunoassay: influence of sex, pregnancy, lactation, anesthesia, hypophysectomy and extrasellar pituitary transplants. Endocrinology 79, 275 (1966)
3. Takahashi, K., Daughaday, W. H., Kipnis, D. M., Regulation of immunoreactive growth hormone secretion in male rats. Endocrinology 88, 909 (1971)
4. Kokka, N., Garcia, J. F., George, R. et al., Growth hormone and ACTH secretion: evidence for an inverse relationship in rats. Endocrinology 90, 735 (1972)
5. Collu, R., Jequier, J. C., Letarte, J. et al., Effect of stress and hypothalamic differentiation on the secrection of growth hormone in the rat. Neuroendocrinology 11, 183 (1973)
6. Brown, G. M., Uhlir, I. V., Seggie, J. et al., Effect of septal lesions on plasma levels of MSH, corticosterone, GH, and prolactin before and after exposure to novel environment: role of MSH in the septal syndrome. Endocrinology 94, 593 (1974)
7. Momany, F. A., Bowers, C. Y., Reynolds, G. A. et al., Conformational energy studies and in vitro and in vivo activity data on growth hormone-releasing peptides. Endocrinology 114, 1531 (1984)
8. Bowers, C. Y., Momany, F. A., Reynolds, G. A. et al., On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114, 1537 (1984)
9. Bowers, C. Y., GH releasing peptides-structure and kinetics. J. Pediatr. Endocrinol. 6, 21 (1993)
10. Patchett, A. A., Nargund, R. P., Tata, J. R. et al., Design and biological activities of L-163,191 (MK-677): a potent, orally active growth hormone secretagogue. Proc. Natl. Acad. Sci. USA 92, 7001 (1995)
11. Hansen, B. S., Raun, K., Nielsen, K. K. et al., Pharmacological characterization of a new oral GH secretagogue, NN703. Eur. J. Endocrinol. 141, 180 (1999)
12. Pan, L. C., Carpino, P. A., Lefker, B. A. et al., Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogue. Endocrine 14, 121 (2001)
13. Howard, A. D., Feighner, S. D., Cully, D. F. et al., A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273, 974 (1996)
14. Kojima, M., Hosoda, H., Date, Y. et al., Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656 (1999)
15. Date, Y., Murakami, N., Kojima, M. et al., Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem. Biophys. Res. Commun. 275, 477 (2000)
16. Wren, A. M., Small, C. J., Ward, H. L. et al., The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141, 4325 (2000)
17. Tschõp, M., Smiley, D. L., Heiman, M. L., Ghrelin induces adiposity in rodents. Nature 407, 908 (2000)
18. Bowers, C. Y., Sartor, A. O., Reynolds, G. A. et al., On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 128, 2027 (1991)
19. Ghigo, E., Arvat, E., Camanni, F., Orally active growth hormone secretagogues: state of the art and clinical perspectives. Ann. Med. 30, 159 (1998)
20. Date, Y., Murakami, N., Toshinai, K. et al., The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123, 1120 (2002)
21. Sawada, H., Sugihara, H., Onose, H. et al., Effect of D-Ala-D-beta Nal-Ala-Trp-D-phe-Lys-NH2 (KP-102) on GH secretion in urethane-anesthetized rats. Regul. Pept. 53, 195 (1994)
22. Tiulpakov, A. N., Brock, C. G., Pringle, P. J. et al., GH responses to intravenous bolus infusions of GH releasing hormone and GH releasing peptide 2 separately and in combination in adult volunteers. Clin. Endocrinol. (Oxf.) 43, 347 (1995)
23. Roh, S. G., Matsunaga, N., Hidaka, S. et al., Characteristics of growth hormone secretion responsiveness to growth hormone-releasing peptide-2 (GHRP-2 or KP-102) in calves. Endocr. J. 43, 291 (1996)
24. Nakagawa, T., Ukai, K., Ohyama, T. et al., Effects of the synthesized growth hormone releasing peptide, KP-102, on growth hormone release in sodium glutamate monohydrated-treated low growth rats. Life Sci. 59, 705 (1996)
25. Clark, R. G., Robinson, I. C., Growth hormone responses to multiple injections of a fragment of human growth hormone-releasing factor in conscious male and female rats. J. Endocrinol. 106, 281 (1985)
26. Paxions, G., Watson, C., The rat brain in stereotaxic coordinates. Academic Press, New York (1982)
27. Cheng, K., Chan, W. W., Butler, B. et al., Stimulation of growth hormone release from rat primary pituitary cells by L-692,429, a novel non-peptidyl GH secretagogue. Endocrinology 132, 2729 (1993)
28. Tannenbaum, G. S., Martin, J. B., Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat. Endocrinology 98, 562 (1976)
29. Martin, J. B., Brazeau, P, Tannenbaum, G. S. et al., Neuroendocrine organization of growth hormone regulation. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 56, 329 (1978)
30. Tannenbaum, G.S., Painson, J.C., Lapointe, M. et al., Interplay of somatostatin and growth hormone-releasing hormone in genesis of episodic growth hormone secretion. Metabolism 39 (Suppl.), 35 (1990)
31. Terry, L. C., Willoughby, J. O., Braseau, P et al., Antiserum to somatostatin prevents stress-induced inhibition of growth hormone secretion in the rat. Science 192, 565 (1976)
32. Chihara, K., Arimura, A., Serially A. V., Immunoreactive somatostatin in rat hypophyseal portal blood: effect of anesthetics. Endocrinology 104, 1434 (1979)
33. Martin, J. B., Studies on the mechanism of pentobarbital-induced GH release in the rat. Neuroendocrinology 13, 339 (1974)
34. William, B., The absence of an age-related change in the pituitary response to growth hormone-releasing factor in rats. Neuroendocrinology 37, 463 (1983)
35. Abribat, T., Regnier, A., Morre, M., Growth hormone response induced by synthetic human growth hormone-releasing factor (1-44) in healthy dogs. Zentralbl. Veterinärmed. A 36, 367 (1989)
36. Nakai, T., Measurements of serum pituitary hormones and dynamic tests to evaluate the pituitary functions. Nippon Rinsho 51, 2667 (1993)
37. Shimada, O., Tosaka-Shimada, H., Ishikawa, H., Morphological effects of somatostatin on rat somatotrophs previously activated by growth hormone-releasing factor. Cell. Tissue Res. 261, 219 (1990)
38. Frieboes, R. M., Murck, H., Maier, P. et al., Growth hormone-releasing peptide-6 stimulated sleep, growth hormone, ACTH and cortisol release in normal man. Neuroendocrinology 61, 584 (1995)
39. Thomas, G. B., Fairhall, K. M., Robinson, I. C., Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Endocrinology 138, 1585 (1997)
40. Ghigo, E., Arvat, E., Giorolano, R. et al., Biologic activities of growth hormone secretagogues in humans. Endocrine 14, 87 (2001)
41. Roh, S. G., He, M. L., Matsunaga, N. et al., Mechanism of action of growth hormone-releasing peptide-2 in bovine pituitary cells. J. Anim. Sci. 75, 2744 (1997)
42. Dickson, S. L., Leng, G., Robinson, I. C. A. F., Systemic administration of growth hormone-releasing peptide (GHRP-6) activates hypothalamic arcuate neurons. Neuroscience 53, 303 (1993)
43. Honda, K., Bailey, A. R., Bull, P. M. et al., An electro-physiological and morphological investigation of the projections of growth hormone-releasing peptide-6-responsive neurons in the rat arcuate nucleus to the median eminence and to the paraventricular nucleus. Neuroscience 90, 875 (1999)
44. Guan, X. M., Yu, H., Palyha, O. C. et al., Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res. Mol. Brain Res. 48, 23 (1997)